Lilli Manzi nag-retweet

Proud to contribute to this fantastic issue with the main results of the POMPEII prospective study on cangrelor in patients with ACS or CCS
@espogiov @vlgmrc @CirilloPlinio @piccoloraf @franzone_anna @llddss80 @DSCastiello @LilliManzi @me_canonico @MAvvedimento
EuroIntervention@EuroInterventio
🔥 🔥 Our 20th anniversary EuroPCR edition OUT TODAY with: 📌 State-of-the-Art on the treatment of PFO; 📌 Expert review of leaflet modification techniques during TAVI; 📌 Long-term structural valve deterioration after TAVI; 📌 Ticagrelor monotherapy; 📌 Cangrelor in acute and chronic coronary syndromes; 📌 Rationale and design of the COMPARE STEMI ONE trial; 📌 OCT versus IVUS in patients with and without ACS; DON'T MISS IT! ow.ly/4p9L50VTLjA #EAPCI #EuroPCR #interventionalcardiology
English


